Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...

Most patients recovering from acute hepatitis B clear HBsAg within 4-6 months after onset of infection; however, persistence of HBsAg for more than 6 months refers to chronic HBV infection.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

may shortly become the primary treatment of choice for patients with chronic hepatitis B.

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

The hepatitis B virus can cause a mild, temporary (acute) illness or a serious, lifelong (chronic) disease. An estimated 880,000 to 1.89 million people in the United States have chronic hepatitis ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

DelveInsight’s, “Chronic Hepatitis B Virus Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus pipeline ...

China: A recent retrospective cohort study has highlighted the significant role of pulmonary infections in influencing ...